The store will not work correctly when cookies are disabled.
(E)-N-hydroxy-3-(2-methoxy-5-(methyl(2-methylquinazolin-4-yl)amino)phenyl)acrylamide
ID: ALA5199279
PubChem CID: 168291933
Max Phase: Preclinical
Molecular Formula: C20H20N4O3
Molecular Weight: 364.41
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1/C=C/C(=O)NO
Standard InChI: InChI=1S/C20H20N4O3/c1-13-21-17-7-5-4-6-16(17)20(22-13)24(2)15-9-10-18(27-3)14(12-15)8-11-19(25)23-26/h4-12,26H,1-3H3,(H,23,25)/b11-8+
Standard InChI Key: ZDYZZJZYCUHGLX-DHZHZOJOSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-3.5719 0.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8574 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1454 0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1454 -0.6183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8555 -1.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5719 -0.6220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2838 0.6183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2838 1.4435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5737 1.8553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8574 1.4472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4308 0.6193 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7162 0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0014 0.6192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7106 0.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7106 -0.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0002 -1.0300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7162 -0.6219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4252 -1.0307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1399 -0.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4308 1.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8555 -1.8553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4252 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1399 0.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8546 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5692 0.2072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8546 1.4450 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2838 0.6198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
2 10 1 0
3 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
15 18 1 0
18 19 1 0
11 20 1 0
5 21 1 0
14 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
24 26 2 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.41 | Molecular Weight (Monoisotopic): 364.1535 | AlogP: 3.23 | #Rotatable Bonds: 5 |
Polar Surface Area: 87.58 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.55 | CX Basic pKa: 4.93 | CX LogP: 3.27 | CX LogD: 3.26 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.41 | Np Likeness Score: -0.71 |
References
1. Hauguel C, Ducellier S, Provot O, Ibrahim N, Lamaa D, Balcerowiak C, Letribot B, Nascimento M, Blanchard V, Askenatzis L, Levaique H, Bignon J, Baschieri F, Bauvais C, Bollot G, Renko D, Deroussent A, Prost B, Laisne MC, Michallet S, Lafanechère L, Papot S, Montagnac G, Tran C, Alami M, Apcher S, Hamze A.. (2022) Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors., 240 [PMID:35797900] [10.1016/j.ejmech.2022.114573] |